The group provides global payer research and market access strategy advice to clients in the biopharmaceutical industry. A track record of 800 projects – conducted across more than 40 countries and all major therapy areas – ensures a deep understanding of payer systems and market access dynamics. Established relationships with more than 1600 payers cover the full range of pricing and market access stakeholders. Key offerings from the group include:
- Qualitative and semi-quantitative payer research and market access strategy development undertaken across the product lifecycle
- Pricing and reimbursement advice as part of due diligence and product acquisition activities
- Guidance on clinical development strategies required to support optimal market access status
- A dedicated emerging markets practice
- A specific function providing solutions for coverage and reimbursement in the United States
